Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Diltiazem, a calcium channel blocker used for high blood pressure, angina, and certain arrhythmias, commonly causes swollen ankles and feet (peripheral edema), a slowed heart rate, dizziness, flushing, headache, fatigue, and constipation. Symptoms that warrant prompt medical attention include a pulse under 50 beats per minute, fainting or near-fainting, shortness of breath, rapid weight gain or worsening leg swelling, chest pain, very low blood pressure readings, a slow or irregular heartbeat, or signs of liver trouble such as yellowing skin, dark urine, or severe abdominal pain. Dose, other heart medications such as beta blockers or digoxin, kidney and liver function, and whether you take the immediate release or extended release form all change which effects are expected versus concerning, so see below for the complete details before deciding what to report.
If swelling, a sluggish pulse, or lightheadedness has you wondering whether this is a normal adjustment or something your prescriber needs to hear about today, a free, instant, online symptom check can help you organize your symptoms and understand what typically drives them. It takes only a few minutes, is available any time without an appointment, and gives you clearer language and next steps to bring to your pharmacist or doctor.
Last reviewed for medical accuracy: 09/28/2026
Diltiazem is a calcium-channel blocker commonly prescribed for high blood pressure, chest pain (angina) and certain heart rhythm problems. Like all medications, it can cause side effects. Two issues people often ask about are swollen ankles (peripheral edema) and a slow pulse (bradycardia). This guide explains why these happen, what to watch for, and when to speak up.
Diltiazem relaxes blood vessels and slows the heart’s electrical signals. That reduces blood pressure, eases chest pain and helps certain arrhythmias. Because it affects blood vessels and heart rate, it can also cause:
Knowing which effects are mild and which need attention helps you stay safe and comfortable.
Most people tolerate diltiazem well. Common side effects tend to be mild and may improve as your body adjusts. They include:
If these persist or worsen, talk with your doctor about dose adjustments or alternatives.
Swollen ankles (peripheral edema) happen because diltiazem widens blood vessels. Wider vessels can let fluid leak into nearby tissues. You may notice:
If swelling is mild and stable, these measures may be enough. But if it worsens or you develop other symptoms, read on.
Diltiazem slows the electrical signals in your heart’s AV node. This can lead to a slower heart rate, which may feel like:
A slightly slower pulse is expected. However, if it drops too low or you feel unwell, it’s time to check in with your doctor.
Most side effects don’t require emergency care, but some warning signs mean you should act fast. Contact your healthcare provider or seek urgent help if you experience:
In these cases, you may need a dose change, additional tests (like an EKG or blood work) or a different medication.
Beyond swelling and bradycardia, diltiazem can rarely cause:
Report any of these immediately to your provider.
Clear, specific information helps your doctor decide if diltiazem is right for you or if changes are needed.
If you’re unsure whether to seek help right away, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can guide you on next steps and help you gather details to discuss with your healthcare provider.
Diltiazem effectively lowers blood pressure, controls chest pain and stabilizes certain heart rhythms. Most people find the benefits outweigh mild side effects. Stick with your regimen unless your doctor advises otherwise.
However, never ignore serious or rapidly worsening symptoms. Prompt reporting can prevent complications and keep you on track.
When in doubt, reach out. It’s better to have a quick check-in than risk a serious event.
Always follow your doctor’s instructions on dosing and monitoring. Never stop diltiazem suddenly—doing so can cause rebound high blood pressure or chest pain.
Speak to a doctor about anything that could be life-threatening or serious. Your health matters, and prompt action can make all the difference.
(References)
* Cardelús I, Bou J, Llenas J, Berga P, Gristwood RW. Cardiovascular effects of LAS 30538, a new vascular selective Ca(2+)-channel blocker. J Pharm Pharmacol. 1992 Oct;44(10):830-5. doi: 10.1111/j.2042-7158.1992.tb03214.x. PMID: 1360509.
* Lechner W, Marth C, Keene F. Calcium antagonists for uterine relaxation. Gynecol Obstet Invest. 1989;28(3):144-6. doi: 10.1159/000293551. PMID: 2807036.
* Swingle KF, Reiter MJ. Inhibition of Paf-acether-induced edema of the rat's paw. Agents Actions. 1986 Jun;18(3-4):359-65. doi: 10.1007/BF01964997. PMID: 2875631.
* Andrivet P, Fechner J. [Efficacy of intravenous administration of calcium on sinus dysfunction developed under diltiazem. Apropos of 4 cases]. Arch Mal Coeur Vaiss. 1988 Mar;81(3):331-3. PMID: 3134871.
* Takatsu F, Nishiyama A, Shiga Y, Watarai M, Shimizu S. Long-term follow-up of coronary narrowing with spasm. Int J Cardiol. 1994 Dec;47(1 Suppl):S27-31. doi: 10.1016/0167-5273(94)90323-9. PMID: 7737749.
* Harrington D, Coltart DJ. Diltiazem hydrochloride. Br J Hosp Med. 1994 Oct 19-Nov 1;52(8):413-5. PMID: 7858832.
* Thakrar R, Shulman R, Bellingan G, Singer M. Management of a mixed overdose of calcium channel blockers, β-blockers and statins. BMJ Case Rep. 2014 Jun 6;2014. doi: 10.1136/bcr-2014-204732. Epub 2014 Jun 6. PMID: 24907219; PMCID: PMC4054325.
* Ryuge A, Shimizu H, Ohyama Y, Yamaguchi M, Nomura A, Maruyama S, Kitamura H, Fujita Y. Ischemic Acute Tubular Necrosis due to Diltiazem Overdose. Intern Med. 2016;55(9):1149-51. doi: 10.2169/internalmedicine.55.5232. Epub 2016 May 1. PMID: 27150870.
* Ishii H, Yokota N, Bando Y, Otori K. [Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir]. Yakugaku Zasshi. 2022;142(10):1125-1127. doi: 10.1248/yakushi.22-00099. PMID: 36184446.
* Sharda SC, Bhatia MS. Comparison of diltiazem and metoprolol for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis. Indian Heart J. 2022 Nov-Dec;74(6):494-499. doi: 10.1016/j.ihj.2022.10.195. Epub 2022 Nov 2. PMID: 36334652; PMCID: PMC9773285.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.